Margetuximab
What Is Margetuximab?[edit | edit source]
- Margetuximab (Margenza) is a HER2/neu receptor antagonist.
What are the uses of this medicine?[edit | edit source]
- Margetuximab (Margenza) is indicated, in combination with chemotherapy, for the treatment of adult patients with metastatic HER2-positive breast cancer who have received two or more prior anti-HER2 regimens, at least one of which was for metastatic disease.
How does this medicine work?[edit | edit source]
- Margetuximab-cmkb binds to the extracellular domain of the human epidermal growth factor receptor 2 protein (HER2).
- Upon binding to HER2-expressing tumor cells, margetuximab-cmkb inhibits tumor cell proliferation, reduces shedding of the HER2 extracellular domain and mediates antibody-dependent cellular cytotoxicity (ADCC).
Who Should Not Use this medicine ?[edit | edit source]
- This medicine have no usage limitations
Is this medicine FDA approved?[edit | edit source]
- It was approved for use in the United States in 2020.
How should this medicine be used?[edit | edit source]
- Administer Margenza as an intravenous infusion at 15 mg/kg over 120 minutes for the initial dose, then over a minimum of 30 minutes every 3 weeks for all subsequent doses.
- On days when both Margenza and chemotherapy are to be administered, Margenza may be administered immediately after chemotherapy completion.
What are the dosage forms and brand names of this medicine?[edit | edit source]
This medicine is available in fallowing doasage form: As injections: 250 mg/10 mL (25 mg/mL) in a single-dose vial
This medicine is available in fallowing brand namesː
- Margenza
What side effects can this medication cause?[edit | edit source]
Common possible side effects and laboratory abnormalities of this medicine include:
- fatigue/asthenia
- nausea
- diarrhea
- vomiting
- constipation
- headache
- pyrexia
- alopecia
- abdominal pain
- peripheral neuropathy
- arthralgia/myalgia
- cough
- decreased appetite
- dyspnea
- infusion-related reactions
- palmar-plantar erythrodysesthesia* extremity pain
What special precautions should I follow?[edit | edit source]
- Margenza may lead to reductions in left ventricular ejection fraction (LVEF).
- Evaluate cardiac function prior to and during treatment.
- Discontinue Margenza treatment for a confirmed clinically significant decrease in left ventricular function.
- Margenza can cause fetal harm when administered to a pregnant woman.
- Advise patients of the risk and need for effective contraception.
- If a significant infusion-associated reaction occurs, slow or interrupt the infusion and administer appropriate medical therapies.
What to do in case of emergency/overdose?[edit | edit source]
- In case of overdose, call the poison control helpline of your country. In the United States, call 1-800-222-1222.
- Overdose related information is also available online at poisonhelp.org/help.
- In the event that the victim has collapsed, had a seizure, has trouble breathing, or can't be awakened, immediately call emergency services. In the United States, call 911.
Can this medicine be used in pregnancy?[edit | edit source]
- Exposure to Margenza during pregnancy can cause embryo-fetal harm.
Can this medicine be used in children?[edit | edit source]
- Safety and effectiveness of Margenza have not been established in pediatric patients.
What should I know about storage and disposal of this medication?[edit | edit source]
- Store vials refrigerated at 2°C to 8°C (36°F to 46°F) in original carton to protect from light until time of use.
- Do not freeze.
- Do not shake.
Margetuximab Resources | ||
---|---|---|
|
|
Navigation: Wellness - Encyclopedia - Health topics - Disease Index - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Contributors: Deepika vegiraju